A multi-centre, double-blind, randomised, placebo-controlled crossover study of tiotropium treatment in adult patients with stable, non-cystic fibrosis bronchiectasis.

Trial Profile

A multi-centre, double-blind, randomised, placebo-controlled crossover study of tiotropium treatment in adult patients with stable, non-cystic fibrosis bronchiectasis.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jul 2016

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Bronchiectasis
  • Focus Therapeutic Use
  • Acronyms ROBUST
  • Most Recent Events

    • 27 Jul 2016 Status changed from recruiting to completed.
    • 21 Jun 2012 Actual initiation date 5 Mar 2012 added as reported by Australian New Zealand Clinical Trials Registry record.
    • 21 Jun 2012 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top